. . . . . . . "[Moreover, assessment of tumor expression of IGF-II, phospho-IGF-IR, or PTEN status may help select patients with ovarian cancer who are most likely to benefit from ganitumab.Clin Cancer Res; 20(11); 2947-58.�2014 AACR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:15:45+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .